Muller CP - Search Results

1

Waning antibodies in measles and rubella vaccinees--a longitudinal study.

Kremer JR, Schneider F, Muller CP. Kremer JR, et al. Among authors: muller cp. Vaccine. 2006 Mar 24;24(14):2594-601. doi: 10.1016/j.vaccine.2005.12.015. Epub 2005 Dec 27. Vaccine. 2006. PMID: 16427163

2

Genetic variability of measles viruses circulating in the Benelux.

Hanses F, van Binnendijk R, Ammerlaan W, Truong AT, de Rond L, Schneider F, Muller CP. Hanses F, et al. Among authors: muller cp. Arch Virol. 2000;145(3):541-51. doi: 10.1007/s007050050045. Arch Virol. 2000. PMID: 10795521

3

Molecular epidemiology of Nigerian and Ghanaian measles virus isolates reveals a genotype circulating widely in western and central Africa.

Hanses F, Truong AT, Ammerlaan W, Ikusika O, Adu F, Oyefolu AO, Omilabu SA, Muller CP. Hanses F, et al. Among authors: muller cp. J Gen Virol. 1999 Apr;80 ( Pt 4):871-877. doi: 10.1099/0022-1317-80-4-871. J Gen Virol. 1999. PMID: 10211955

4

Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response.

Ertl OT, Wenz DC, Bouche FB, Berbers GA, Muller CP. Ertl OT, et al. Among authors: muller cp. Arch Virol. 2003 Nov;148(11):2195-206. doi: 10.1007/s00705-003-0159-9. Arch Virol. 2003. PMID: 14579178

5

New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules.

El Kasmi KC, Muller CP. El Kasmi KC, et al. Among authors: muller cp. Vaccine. 2001 Mar 21;19(17-19):2238-44. doi: 10.1016/s0264-410x(00)00452-7. Vaccine. 2001. PMID: 11257340 Review.

6

Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.

Muller CP, Schroeder T, Tu R, Brons NH, Jung G, Schneider F, Wiesmüller KH. Muller CP, et al. Scand J Immunol. 1993 Nov;38(5):463-71. doi: 10.1111/j.1365-3083.1993.tb02589.x. Scand J Immunol. 1993. PMID: 7694357

7

Genetic analysis of Asian measles virus strains--new endemic genotype in Nepal.

Truong AT, Mulders MN, Gautam DC, Ammerlaan W, de Swart RL, King CC, Osterhaus AD, Muller CP. Truong AT, et al. Among authors: muller cp. Virus Res. 2001 Jul;76(1):71-8. doi: 10.1016/s0168-1702(01)00255-6. Virus Res. 2001. PMID: 11376847

8

The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.

El Kasmi KC, Theisen D, Brons NH, Muller CP. El Kasmi KC, et al. Among authors: muller cp. Mol Immunol. 1998 Oct;35(14-15):905-18. doi: 10.1016/s0161-5890(98)00087-x. Mol Immunol. 1998. PMID: 9881686

9

Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors.

Huiss S, Damien B, Schneider F, Muller CP. Huiss S, et al. Among authors: muller cp. Clin Exp Immunol. 1997 Sep;109(3):416-20. doi: 10.1046/j.1365-2249.1997.00137.x. Clin Exp Immunol. 1997. PMID: 9328115 Free PMC article.

10

Measles elimination: old and new challenges?

Muller CP. Muller CP. Vaccine. 2001 Mar 21;19(17-19):2258-61. doi: 10.1016/s0264-410x(00)00455-2. Vaccine. 2001. PMID: 11257344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results